Page last updated: 2024-08-23

atomoxetine hydrochloride and Psychoses

atomoxetine hydrochloride has been researched along with Psychoses in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carvalho, AF; Correll, CU; de Bartolomeis, A; Fornaro, M; Köhler, CA; Solmi, M; Stubbs, B; Toyoshima, K; Veronese, N	1
Merrill, RM; Palmer, CA; Thygerson, SM	1
Ball, MP; Buchanan, RW; Feldman, S; Kelly, DL; McMahon, RP; Warren, KR	1
Adli, M; Bauer, M; Burghardt, R; Pilhatsch, MK; Wandinger, KP	1

Reviews

1 review(s) available for atomoxetine hydrochloride and Psychoses

Article	Year
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder. CNS spectrums, 2019, Volume: 24, Issue:5 Topics: Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention; Executive Function; Humans; Memory, Short-Term; Methylphenidate; Problem Solving; Psychotic Disorders; Schizophrenia	2019

Article

Year

Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.

CNS spectrums, 2019, Volume: 24, Issue:5

Topics: Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention; Executive Function; Humans; Memory, Short-Term; Methylphenidate; Problem Solving; Psychotic Disorders; Schizophrenia

2019

Trials

1 trial(s) available for atomoxetine hydrochloride and Psychoses

Article	Year
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. Clinical schizophrenia & related psychoses, 2011, Volume: 5, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Appetite Depressants; Atomoxetine Hydrochloride; Attention; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Clozapine; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Exercise; Female; Humans; Life Style; Male; Maryland; Middle Aged; Neuropsychological Tests; Obesity; Olanzapine; Propylamines; Psychotic Disorders; Schizophrenia	2011

Article

Year

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.

Clinical schizophrenia & related psychoses, 2011, Volume: 5, Issue:1

Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Appetite Depressants; Atomoxetine Hydrochloride; Attention; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Clozapine; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Exercise; Female; Humans; Life Style; Male; Maryland; Middle Aged; Neuropsychological Tests; Obesity; Olanzapine; Propylamines; Psychotic Disorders; Schizophrenia

2011

Other Studies

2 other study(ies) available for atomoxetine hydrochloride and Psychoses

Article	Year
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy. Pharmacopsychiatry, 2016, Volume: 49, Issue:2 Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Neurotic Disorders; Personality Disorders; Psychoses, Substance-Induced; Psychotic Disorders; United States; Wounds and Injuries; Young Adult	2016
Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report. Pharmacopsychiatry, 2006, Volume: 39, Issue:2 Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Nortriptyline; Propylamines; Psychotic Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2006

Article

Year

Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.

Pharmacopsychiatry, 2016, Volume: 49, Issue:2

Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Neurotic Disorders; Personality Disorders; Psychoses, Substance-Induced; Psychotic Disorders; United States; Wounds and Injuries; Young Adult

2016

Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.

Pharmacopsychiatry, 2006, Volume: 39, Issue:2

Topics: Atomoxetine Hydrochloride; Clozapine; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Nortriptyline; Propylamines; Psychotic Disorders; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index

2006